PuSH - Publikationsserver des Helmholtz Zentrums München

63 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Effner, R. et al.: Effects of environmental signaling in patients with STAT1/STAT3-dependent primary immunodeficiencies. Exp. Dermatol. 28, E70-E70 (2019)
2.
Eyerich, K. et al.: Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council. J. Allergy Clin. Immunol. 143, 36-45 (2019)
3.
Matthias, J.* et al.: Sodium chloride is an ionic checkpoint for human TH2 cells and shapes the atopic skin microenvironment. Sci. Transl. Med. 11:eaau0683 (2019)
4.
Frey, K.M.* ; Lauffer, F.* ; Garzorz-Stark, N.* ; Eyerich, S. & Eyerich, K.: Mapping of disease severity in patients with scleroderma. Allergy 73, 730-730 (2018)
5.
Aguirre Bueno, J. et al.: Precision assessment of label-free psoriasis biomarkers with ultra-broadband optoacoustic mesoscopy. Nat. Bio. Eng. 1:0068 (2017)
6.
Garzorz-Stark, N. et al.: The imiquimod model as a model for psoriasis and/or eczema in humans? Exp. Dermatol. 26, E68-E68 (2017)
7.
Kuepper, M.K.* et al.: Characterization of multiple B cell subsets in peripheral blood and skin biopsies of psoriasis patients identifies a correlation of plasma and regulatory B cells and disease severity. Exp. Dermatol. 26, E69-E70 (2017)
8.
Lauffer, F.* et al.: Interface dermatitis shows a distinctive molecular signature independent from individual disease background. Exp. Dermatol. 26, E61-E61 (2017)
9.
Wang, R.* et al.: Cellular mechanism of action of IgE-specific immunoadsorption in treatment of patients with severe atopic eczema. Exp. Dermatol. 26, E101-E101 (2017)
10.
Bieber, T.* et al.: Global Allergy Forum and 3rd Davos Declaration 2015: Atopic dermatitis/Eczema: Challenges and opportunities toward precision medicine. Allergy 71, 588-592 (2016)
11.
Garzorz-Stark, N.* et al.: Pyoderma gangrenosum, Acne, Psoriasis, Arthritis and Suppurative Hidradenitis (PAPASH)-syndrome: A new entity within the spectrum of autoinflammatory syndromes? J. Eur. Acad. Dermatol. Venereol. 30, 141–143 (2016)
12.
Garzorz-Stark, N.* et al.: Newly acquired kiwi fruit allergy after bone marrow transplantation from a kiwi-allergic donor. J. Eur. Acad. Dermatol. Venereol. 30, 1136-1139 (2016)
13.
Garzorz-Stark, N.* et al.: A novel molecular disease classifier for psoriasis and eczema. Exp. Dermatol. 25, 767-774 (2016)
14.
Kuepper, M.K.* et al.: Characterization of multiple B cell subsets in peripheral blood of psoriasis patients identifies a correlation of regulatory B cells and disease severity. J. Invest. Dermatol. 136, S217-S217 (2016)
15.
Lauffer, F.* et al.: Interface dermatitis shows a distinctive molecular signature independent from individual disease background. J. Invest. Dermatol. 136, S219-S219 (2016)
16.
Lovaszi, M.* et al.: Characterization of the immunomodulatory effects of sebocytes on macrophages. J. Invest. Dermatol. 136, S231-S231 (2016)
17.
Rodrguez, E.* et al.: Metabolomic profiling of psoriasis patients before and after systemic treatment. Exp. Dermatol. 25, E11 (2016)
18.
Wang, R.* et al.: Cellular mechanism of action of IgE-specific immunoadsorption in treatment of patients with severe atopic eczema. J. Invest. Dermatol. 136, S168-S168 (2016)
19.
Werfel, T.* et al.: Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J. Allergy Clin. Immunol. 138, 336-349 (2016)
20.
Avitabile, S.* et al.: Interleukin-22 promotes wound repair in diabetes by improving keratinocyte pro-healing functions. J. Invest. Dermatol. 135, 2862-2870 (2015)